Extremely Inefficient Star Formation in the Outer Disks of Nearby Galaxies

(Abridged) We combine data from The HI Nearby Galaxy Survey and the GALEX Nearby Galaxy Survey to study the relationship between atomic hydrogen (HI) and far-ultraviolet (FUV) emission outside the optical radius (r25) in 17 spiral and 5 dwarf galaxies. In this regime, HI is likely to represent most of the ISM and FUV emission to trace recent star formation with little bias due to extinction, so that the two quantities closely trace the underlying relationship between gas and star formation rate (SFR). The azimuthally averaged HI and FUV intensities both decline with increasing radius in this regime, with the scale length of the FUV profile typically half that of the HI profile. Despite the mismatch in profiles, there is a significant spatial correlation (at 15" resolution) between local FUV and HI intensities; near r25 this correlation is quite strong, in fact stronger than anywhere inside r25, and shows a decline towards larger radii. The star formation efficiency (SFE) - defined as the ratio of FUV/HI and thus the inverse of the gas depletion time - decreases with galactocentric radius across the outer disks, though much shallower than across the optical disks. On average, we find the gas depletion times to be well above a Hubble time (~10^11 yr). We observe a clear relationship between FUV/HI and HI column in the outer disks, with the SFE increasing with increasing HI column. Despite observing systematic variations in FUV/HI, we find no clear evidence for step-function type star formation thresholds. When compared with results from inside r25, we find outer disk star formation to be distinct in several ways: it is extremely inefficient (depletion times of many Hubble times) with column densities and SFRs lower than found anywhere inside the optical disks. It appears that the HI column is one of, perhaps even the key environmental factor in setting the SFR in outer galaxy disks.Comment: Accepted for Publication in The Astronomical Journa

Is increased antidepressant exposure a contributory factor to the obesity pandemic?

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/Major depressive disorder (MDD) and obesity are both common heterogeneous disorders with complex aetiology, with a major impact on public health. Antidepressant prescribing has risen nearly 400% since 1988, according to data from the Centers for Disease Control and Prevention (CDC). In parallel, adult obesity rates have doubled since 1980, from 15 to 30 percent, while childhood obesity rates have more than tripled. Rising obesity rates have significant health consequences, contributing to increased rates of more than thirty serious diseases. Despite the concomitant rise of antidepressant use and of the obesity rates in Western societies, the association between the two, as well as the mechanisms underlying antidepressant-induced weight gain, remain under explored. In this review, we highlight the complex relationship between antidepressant use, MDD and weight gain. Clinical findings have suggested that obesity may increase the risk of developing MDD, and vice versa. Hypothalamic–pituitary–adrenal (HPA) axis activation occurs in the state of stress; concurrently, the HPA axis is also dysregulated in obesity and metabolic syndrome, making it the most well-understood shared common pathophysiological pathway with MDD. Numerous studies have investigated the effects of different classes of antidepressants on body weight. Previous clinical studies suggest that the tricyclics amitriptyline, nortriptyline and imipramine, and the serotonin norepinephrine reuptake inhibitor mirtazapine are associated with weight gain. Despite the fact that selective serotonin reuptake inhibitor (SSRI) use has been associated with weight loss during acute treatment, a number of studies have shown that SSRIs may be associated with long-term risk of weight gain; however, because of high variability and multiple confounds in clinical studies, the long-term effect of SSRI treatment and SSRI exposure on body weight remains unclear. A recently developed animal paradigm shows that the combination of stress and antidepressants followed by long-term high-fat diet results, long after discontinuation of antidepressant treatment, in markedly increased weight, in excess of what is caused by high-fat diet alone. On the basis of existing epidemiological, clinical and preclinical data, we have generated the testable hypothesis that escalatin

Is increased antidepressant exposure a contributory factor to the obesity pandemic?

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/Major depressive disorder (MDD) and obesity are both common heterogeneous disorders with complex aetiology, with a major impact on public health. Antidepressant prescribing has risen nearly 400% since 1988, according to data from the Centers for Disease Control and Prevention (CDC). In parallel, adult obesity rates have doubled since 1980, from 15 to 30 percent, while childhood obesity rates have more than tripled. Rising obesity rates have significant health consequences, contributing to increased rates of more than thirty serious diseases. Despite the concomitant rise of antidepressant use and of the obesity rates in Western societies, the association between the two, as well as the mechanisms underlying antidepressant-induced weight gain, remain under explored. In this review, we highlight the complex relationship between antidepressant use, MDD and weight gain. Clinical findings have suggested that obesity may increase the risk of developing MDD, and vice versa. Hypothalamic–pituitary–adrenal (HPA) axis activation occurs in the state of stress; concurrently, the HPA axis is also dysregulated in obesity and metabolic syndrome, making it the most well-understood shared common pathophysiological pathway with MDD. Numerous studies have investigated the effects of different classes of antidepressants on body weight. Previous clinical studies suggest that the tricyclics amitriptyline, nortriptyline and imipramine, and the serotonin norepinephrine reuptake inhibitor mirtazapine are associated with weight gain. Despite the fact that selective serotonin reuptake inhibitor (SSRI) use has been associated with weight loss during acute treatment, a number of studies have shown that SSRIs may be associated with long-term risk of weight gain; however, because of high variability and multiple confounds in clinical studies, the long-term effect of SSRI treatment and SSRI exposure on body weight remains unclear. A recently developed animal paradigm shows that the combination of stress and antidepressants followed by long-term high-fat diet results, long after discontinuation of antidepressant treatment, in markedly increased weight, in excess of what is caused by high-fat diet alone. On the basis of existing epidemiological, clinical and preclinical data, we have generated the testable hypothesis that escalatin

Congenital leptin deficiency and thyroid function

Thyroid function is closely related to leptin's secretion by the adipose tissue. In states of leptin-deficiency, the circadian rhythm of TSH is altered, leading to central hypothyroidism in animal models. In humans, central hypothyroidism has also been described in rare cases of congenital leptin deficiency. However, the thyroid phenotype in these cases is heterogeneous, with the occurrence of central hypothyroidism in a minority of cases. Here we describe thyroid function in four leptin-deficient humans (2 males aged 5 and 27, and 2 females aged 35 and 40), before and during leptin replacement with recombinant human methionyl leptin (r-metHuLeptin). The child was evaluated for four years, and the adults, for eight years. In addition, the adults were submitted to a brief withdrawal of leptin during six weeks in the sixth year. Our results show that, regardless of leptin replacement, our leptin-deficient patients have normal thyroid function. In spite of having an important role in regulating the hypothalamic-pituitary-thyroidal axis, leptin is not required for normal thyroid function

The volume densities of giant molecular clouds in M83

Using observed GALEX far-ultraviolet (FUV) fluxes and VLA images of the 21-cm HI column densities, along with estimates of the local dust abundances, we measure the volume densities of a sample of actively star-forming giant molecular clouds (GMCs) in the nearby spiral galaxy M83 on a typical resolution scale of 170 pc. Our approach is based on an equilibrium model for the cycle of molecular hydrogen formation on dust grains and photodissociation under the influence of the FUV radiation on the cloud surfaces of GMCs. We find a range of total volume densities on the surface of GMCs in M83, namely 0.1 - 400 cm-3 inside R25, 0.5 - 50 cm-3 outside R25 . Our data include a number of GMCs in the HI ring surrounding this galaxy. Finally, we discuss the effects of observational selection, which may bias our results.Comment: 9 pages, 11 figure

Is increased antidepressant exposure a contributory factor to the obesity pandemic?

Major depressive disorder (MDD) and obesity are both common heterogeneous disorders with complex aetiology, with a major impact on public health. Antidepressant prescribing has risen nearly 400% since 1988, according to data from the Centers for Disease Control and Prevention (CDC). In parallel, adult obesity rates have doubled since 1980, from 15 to 30 percent, while childhood obesity rates have more than tripled. Rising obesity rates have significant health consequences, contributing to increased rates of more than thirty serious diseases. Despite the concomitant rise of antidepressant use and of the obesity rates in Western societies, the association between the two, as well as the mechanisms underlying antidepressant-induced weight gain, remain under explored. In this review, we highlight the complex relationship between antidepressant use, MDD and weight gain. Clinical findings have suggested that obesity may increase the risk of developing MDD, and vice versa. Hypothalamic-pituitary-adrenal (HPA) axis activation occurs in the state of stress; concurrently, the HPA axis is also dysregulated in obesity and metabolic syndrome, making it the most well-understood shared common pathophysiological pathway with MDD. Numerous studies have investigated the effects of different classes of antidepressants on body weight. Previous clinical studies suggest that the tricyclics amitriptyline, nortriptyline and imipramine, and the serotonin norepinephrine reuptake inhibitor mirtazapine are associated with weight gain. Despite the fact that selective serotonin reuptake inhibitor (SSRI) use has been associated with weight loss during acute treatment, a number of studies have shown that SSRIs may be associated with long-term risk of weight gain; however, because of high variability and multiple confounds in clinical studies, the long-term effect of SSRI treatment and SSRI exposure on body weight remains unclear. A recently developed animal paradigm shows that the combination of stress and antidepressants followed by long-term high-fat diet results, long after discontinuation of antidepressant treatment, in markedly increased weight, in excess of what is caused by high-fat diet alone. On the basis of existing epidemiological, clinical and preclinical data, we have generated the testable hypothesis that escalating use of antidepressants, resulting in high rates of antidepressant exposure, might be a contributory factor to the obesity epidemi

Cyclic di-GMP regulates type three secretion system and virulence in Bordetella bronchiseptica

The second messenger cyclic di-GMP (c-di-GMP) is a ubiquitous molecule in bacteria that regulates diverse phenotypes. Among them, motility and biofilm formation are the most studied. Furthermore, c-di-GMP has been suggested to regulate virulence factors, making it important for pathogenesis. Previously, we reported that c-di-GMP regulates biofilm formation and swimming motility in Bordetella bronchiseptica. Here, we present a multi-omics approach for the study of B. bronchiseptica strains expressing different cytoplasmic c-di-GMP levels, including transcriptome sequencing (RNA-seq) and shotgun proteomics with label-free quantification. We detected 64 proteins significantly up- or downregulated in either low or high c-di-GMP levels and 358 genes differentially expressed between strains with high c-di-GMP levels and the wild-type strain. Among them, we found genes for stress-related proteins, genes for nitrogen metabolism enzymes, phage-related genes, and virulence factor genes. Interestingly, we observed that a virulence factor like the type III secretion system (TTSS) was regulated by c-di-GMP. B. bronchiseptica with high c-di-GMP levels showed significantly lower levels of TTSS components like Bsp22, BopN, and Bcr4. These findings were confirmed by independent methods, such as quantitative reverse transcription-PCR (q-RT-PCR) and Western blotting. Higher intracellular levels of c-di-GMP correlated with an impaired capacity to induce cytotoxicity in a eukaryotic cell in vitro and with attenuated virulence in a murine model. This work presents data that support the role that the second messenger c-di-GMP plays in the pathogenesis of Bordetella.Fil: Gutierrez, María de la Paz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; ArgentinaFil: Wong, Ting. West Virginia University; Estados UnidosFil: Damron, F. Heath. West Virginia University; Estados UnidosFil: Fernandez, Julieta. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; ArgentinaFil: Sisti, Federico Bernardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Biotecnología y Biología Molecular. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Instituto de Biotecnología y Biología Molecular; Argentin

A Wide-field High Resolution HI Mosaic of Messier 31: I. Opaque Atomic Gas and Star Formation Rate Density

We have undertaken a deep, wide-field HI imaging survey of M31, reaching a maximum resolution of about 50 pc and 2 km/s across a 95x48 kpc region. The HI mass and brightness sensitivity at 100 pc resolution for a 25 km/s wide spectral feature is 1500 M_Sun and 0.28 K. Our study reveals ubiquitous HI self-opacity features, discernible in the first instance as filamentary local minima in images of the peak HI brightness temperature. Local minima are organized into complexes of more than kpc length and are particularly associated with the leading edge of spiral arm features. Just as in the Galaxy, there is only patchy correspondence of self-opaque features with CO(1-0) emission. Localized opacity corrections to the column density exceed an order of magnitude in many cases and add globally to a 30% increase in the atomic gas mass over that inferred from the integrated brightness under the usual assumption of negligible self-opacity. Opaque atomic gas first increases from 20 to 60 K in spin temperature with radius to 12 kpc but then declines again to 20 K beyond 25 kpc. We have extended the resolved star formation law down to physical scales more than an order of magnitude smaller in area and mass than has been possible previously. The relation between total-gas-mass- and star-formation-rate-density is significantly tighter than that with molecular-mass and is fully consistent in both slope and normalization with the power law index of 1.56 found in the molecule-dominated disk of M51 at 500 pc resolution. Below a gas-mass-density of about 5 M_Sun/pc^2, there is a down-turn in star-formation-rate-density which may represent a real local threshold for massive star formation at a cloud mass of about 5x10^4 M_Sun.Comment: Accepted for publication in ApJ, 34 pages, 20 figure

Giant molecular clouds in the non-grand design spiral galaxy NGC 6946

We present high spatial resolution observations of Giant Molecular Clouds (GMCs) in the eastern part of the nearby spiral galaxy NGC 6946 obtained with the Combined Array for Research in Millimeter-wave Astronomy (CARMA). We have observed 12CO(1-0), 12CO(2-1) and 13CO(1-0), achieving spatial resolutions of 5.4" x 5.0", 2.5" x 2.0" and 5.6" x 5.4" respectively over a region of 6 x 6 kpc. This region extends from 1.5 kpc to 8 kpc galactocentric radius, thus avoiding the intense star formation in the central kpc. We have recovered short-spacing u-v components by using single dish observations from the Nobeyama 45m and IRAM 30m telescopes. Using the automated CPROPS algorithm we identified 44 CO cloud complexes in the 12CO(1-0) map and 64 GMCs in the 12CO(2-1) maps. The sizes, line widths, and luminosities of the GMCs are similar to values found in other extragalactic studies. We have classified the clouds into on-arm and inter-arm clouds based on the stellar mass density traced by the 3.6 um map. On-arm clouds present in general higher star formation rates than clouds located on inter-arm regions. Although the star formation efficiency shows no systematic trend with galactocentric radius, some on-arm clouds -- which are more luminous and more massive compared to inter-arm GMCs -- are also forming stars more efficiently than the rest of the identified GMCs. These structures appear to be located on two specific regions in the spiral arms. One of them shows a strong gradient, suggesting that this region of high star formation efficiency may be the result of gas flow convergence.Comment: 23 pages, 21 figures, 3 tables. To be published in The Astrophysical Journa

The Gas Consumption History to z ~ 4

Using the observations of the star formation rate and HI densities to z ~ 4, with measurements of the Molecular Gas Depletion Rate (MGDR) and local density of H_2 at z = 0, we derive the history of the gas consumption by star formation to z ~ 4. We find that closed-box models in which H_2 is not replenished by HI require improbably large increases in rho(H_2) and a decrease in the MGDR with lookback time that is inconsistent with observations. Allowing the H_2 used in star formation to be replenished by HI does not alleviate the problem because observations show that there is very little evolution of rho(HI) from z = 0 to z = 4. We show that to be consistent with observational constraints, star formation on cosmic timescales must be fueled by intergalactic ionized gas, which may come from either accretion of gas through cold (but ionized) flows or from ionized gas associated with accretion of dark matter halos. We constrain the rate at which the extraglactic ionized gas must be converted into HI and ultimately into H_2. The ionized gas inflow rate roughly traces the SFRD: about 1 - 2 x 10^8 M_sun Gyr^-1 Mpc^-3 from z ~ 1 - 4, decreasing by about an order of magnitude from z=1 to z=0 with details depending largely on MGDR(t). All models considered require the volume averaged density of rho(H_2) to increase by a factor of 1.5 - 10 to z ~ 1.5 over the currently measured value. Because the molecular gas must reside in galaxies, it implies that galaxies at high z must, on average, be more molecule rich than they are at the present epoch, which is consistent with observations. These quantitative results, derived solely from observations, agree well with cosmological simulations.Comment: 11 pages, 6 figures. Accepted for publication in the Astrophysical Journal